La carrera por encontrar la vacuna contra la COVID-19 está logrando grandes pasos. En una reciente publicación, la revista médica “The Lancet”, informó que los resultados preliminares de dos vacunas experimentales han presentado respuesta inmune, sumando esperanza en el marco de la crisis sanitaria.
:quality(75)/cdn.jwplayer.com/v2/media/QxMVfmg2/poster.jpg)
:quality(75)/dvgnzpfv30f28.cloudfront.net/07-21-2020/t_dba566a9955040aa9cfd9dd4ccbcbc79_name_CARRERA_VACUNA.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/X4VBIZZSUJGXBGIJOXH57ZBV3E.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/UCjyX8ro/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/Y7T2AZSULNADRPCZ67S4PFU7XU.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/VYBtNakX/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/o1KPg1hs/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/TvvzxktF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/rtpKhHdf/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/sZx0DQw9/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/4NTPGVDXK5AKDL7JBSUHYV47VA.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/efvtbfKm/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/jLDF76V0/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/QxMVfmg2/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/X4VBIZZSUJGXBGIJOXH57ZBV3E.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/UCjyX8ro/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/Y7T2AZSULNADRPCZ67S4PFU7XU.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Qu9HnWcU/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/IJVmPJJM/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/E5G5HWYWUNHFDHML3RA3HBN6BI.png)
:quality(75)/cdn.jwplayer.com/v2/media/nXbaewgE/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/koNs9MA2/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6bLTGi5d/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/KgeU8b6Q/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/a6mwPQ4X/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/yksVgSj8/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/X3PAJUVAAFHRXHUYV5TON7UAAY.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/wXUo9jVU/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/nu9nKgwG/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/c0S03whF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/azLadx4o/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5XSTUGQ5DI3DYDC3MUSLQL6A.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/9a1H4G0a/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/yOEdb2ys/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/JDVYxTbd/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/LIy1dI2W/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Xv8iJGpA/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JW2JBE7IBZEY5NR2VH4KVTPGZ4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/42WZKDIDGVA6VKQDF75376W2CA.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ENCJ6JEIFZHT5E6UXK3KZ5RCUU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/UZ27WLDNBFBCPCMLG42DQCNJYA.png)